Identification of the angiogenic endothelial-cell growth factor-1/thymidine phosphorylase as a potential target for immunotherapy of cancer
- 15 June 2006
- journal article
- Published by American Society of Hematology in Blood
- Vol. 107 (12) , 4954-4960
Abstract
Characterization of the antigens recognized by tumor-reactive T cells isolated from patients successfully treated with allogeneic HLA-matched hematopoietic stem cell transplantation (SCT) can lead to the identification of clinically relevant target molecules. We isolated tumor-reactive cytotoxic CD8+ T-cell (CTL) clones from a patient successfully treated with donor lymphocyte infusion for relapsed multiple myeloma after allogeneic HLA-matched SCT. Using cDNA expression cloning, the target molecule of an HLA-B7–restricted CTL clone was identified. The CTL clone recognized a minor histocompatibility antigen produced by a single nucleotide polymorphism (SNP) in the angiogenic endothelial-cell growth factor-1 (ECGF1) gene also known as thymidine phosphorylase. The SNP leads to an Arg-to-His substitution in an alternatively translated peptide that is recognized by the CTL. The ECGF1 gene is predominantly expressed in hematopoietic cells, although low expression can also be detected in other tissues. The patient from whom this CTL clone was isolated had mild graft-versus-host disease despite high numbers of circulating ECGF-1–specific T cells as detected by tetramer staining. Because solid tumors expressing ECGF-1 could also be lysed by the CTL, ECGF-1 is an interesting target for immunotherapy of both hematologic and solid tumors.Keywords
This publication has 38 references indexed in Scilit:
- Minor histocompatibility antigen-specific T cells with multiple distinct specificities can be isolated by direct cloning of IFNγ-secreting T cells from patients with relapsed leukemia responding to donor lymphocyte infusionLeukemia, 2004
- New CFSE-based assay to determine susceptibility to lysis by cytotoxic T cells of leukemic precursor cells within a heterogeneous target cell populationBlood, 2004
- Direct cloning of leukemia-reactive T cells from patients treated with donor lymphocyte infusion shows a relative dominance of hematopoiesis-restricted minor histocompatibility antigen HA-1 and HA-2 specific T cellsLeukemia, 2004
- Nonmyeloablative Allogeneic Immunotherapy for Solid TumorsAnnual Review of Medicine, 2004
- Identification of a Polymorphic Gene, BCL2A1, Encoding Two Novel Hematopoietic Lineage-specific Minor Histocompatibility AntigensJournal of Experimental Medicine, 2003
- Producing Nature’s Gene-Chips: The Generation of Peptides for Display by MHC Class I MoleculesAnnual Review of Immunology, 2002
- Molecular Basis for the Inhibition of Hypoxia-Induced Apoptosis by 2-Deoxy-d-riboseBiochemical and Biophysical Research Communications, 2002
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001
- Identification of Genes Coding for Tumor Antigens Recognized by Cytolytic T LymphocytesMethods, 1997
- Identification of a Graft Versus Host Disease-Associated Human Minor Histocompatibility AntigenScience, 1995